There was a study on Sapien 3 and Evolute R recovery rates.
Increase from the baseline for the 6MWT was averaged at about 26-27%% for 30days and an extra 9% 30-60 days.
We are significantly better than both valves. Especially considering %'s are exponential when quoting medical results.
NFA DYOR
Ann: DurAVR First In Human Patient 6 Month Study Follow Up, page-8
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.00 |
Change
0.020(0.11%) |
Mkt cap ! $364.8M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $19.00 | $1.007K | 53 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 843 | $18.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.99 | 212 | 1 |
View Market Depth
| Last trade - 10.00am 30/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |